Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents SCIE SCOPUS

DC Field Value Language
dc.contributor.author Hong, Suckchang -
dc.contributor.author Shin, Yoonho -
dc.contributor.author Jung, Myunggi -
dc.contributor.author Ha, Min Woo -
dc.contributor.author Park, Yohan -
dc.contributor.author Lee, Yeon-Ju -
dc.contributor.author Shin, Jongheon -
dc.contributor.author Oh, Ki Bong -
dc.contributor.author Lee, Sang Kook -
dc.contributor.author Park, Hyeung-geun -
dc.date.accessioned 2020-04-20T03:40:22Z -
dc.date.available 2020-04-20T03:40:22Z -
dc.date.created 2020-01-28 -
dc.date.issued 2015-05-26 -
dc.identifier.issn 0223-5234 -
dc.identifier.uri https://sciwatch.kiost.ac.kr/handle/2020.kiost/2485 -
dc.description.abstract We describe a new concise method for the synthesis of psammaplin A and its analogues, and antitumor activity of psammaplin A analogues. Psammaplin A was obtained with 41% yield in 5 steps from 3-bromo-4-hydroxybenzaldahyde and ethyl acetoacetate via Knoevenagel condensation and alpha-nitrocation as key steps. Twenty eight analogues of psammaplin A were prepared employing the new synthetic approach. Structure-activity relationship study against cytotoxicity reveal that the free oxime group and disulfide functional group were responsible for high cytotoxicity. Also the bromotyrosine component was relatively tolerable and hydrophobic aromatic groups preserved the cytotoxicity. The cytotoxicity of aromatic group is dependent on the size and spatial geometry. Among them, five compounds showed comparable cytotoxicity to psammaplin A. Compound 30 exhibited potential HDAC inhibitory activity and in vivo antitumor activity. (C) 2015 Elsevier Masson SAS. All rights reserved. -
dc.description.uri 1 -
dc.language English -
dc.publisher ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER -
dc.subject HISTONE DEACETYLASE INHIBITORS -
dc.subject RESISTANT STAPHYLOCOCCUS-AUREUS -
dc.subject NATURAL-PRODUCT PSAMMAPLIN -
dc.subject CANCER-CELLS -
dc.subject HDAC INHIBITORS -
dc.subject SPONGE -
dc.subject METABOLITES -
dc.subject DISCOVERY -
dc.subject APOPTOSIS -
dc.subject MRSA -
dc.title Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents -
dc.type Article -
dc.citation.endPage 230 -
dc.citation.startPage 218 -
dc.citation.title EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY -
dc.citation.volume 96 -
dc.contributor.alternativeName 이연주 -
dc.identifier.bibliographicCitation EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.96, pp.218 - 230 -
dc.identifier.doi 10.1016/j.ejmech.2015.04.001 -
dc.identifier.scopusid 2-s2.0-84927672968 -
dc.identifier.wosid 000355712500020 -
dc.type.docType Article -
dc.description.journalClass 1 -
dc.subject.keywordPlus HISTONE DEACETYLASE INHIBITORS -
dc.subject.keywordPlus RESISTANT STAPHYLOCOCCUS-AUREUS -
dc.subject.keywordPlus NATURAL-PRODUCT PSAMMAPLIN -
dc.subject.keywordPlus CANCER-CELLS -
dc.subject.keywordPlus HDAC INHIBITORS -
dc.subject.keywordPlus SPONGE -
dc.subject.keywordPlus METABOLITES -
dc.subject.keywordPlus DISCOVERY -
dc.subject.keywordPlus APOPTOSIS -
dc.subject.keywordPlus MRSA -
dc.subject.keywordAuthor Psammaplin A -
dc.subject.keywordAuthor Structure-activity relationship -
dc.subject.keywordAuthor HDAC -
dc.subject.keywordAuthor Histone deacetylase inhibitor -
dc.relation.journalWebOfScienceCategory Chemistry, Medicinal -
dc.description.journalRegisteredClass scie -
dc.description.journalRegisteredClass scopus -
dc.relation.journalResearchArea Pharmacology & Pharmacy -
Appears in Collections:
Marine Resources & Environment Research Division > Marine Biotechnology &Bioresource Research Department > 1. Journal Articles
Files in This Item:
There are no files associated with this item.

qrcode

Items in ScienceWatch@KIOST are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse